X4 Pharmaceuticals Ownership | Who Owns X4 Pharmaceuticals?
X4 Pharmaceuticals Ownership Summary
X4 Pharmaceuticals is owned by 499.03% institutional investors, 1.15% insiders. Empery asset management, lp is the largest institutional shareholder, holding 120.75% of XFOR shares. Fidelity Small Cap Growth is the top mutual fund, with 3.72% of its assets in X4 Pharmaceuticals shares.
XFOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | X4 Pharmaceuticals | 499.03% | 1.15% | -400.18% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Empery asset management, lp | 8.95M | 120.75% | $35.80B |
| Morgan stanley | 8.21M | 110.72% | $32.83M |
| Vanguard group | 3.42M | 46.18% | $13.69M |
| Rosalind advisors | 2.61M | 35.15% | $10.42M |
| Nantahala capital management | 2.45M | 33.04% | $9.80M |
| Bain capital life sciences investors | 2.44M | 32.87% | $8.33M |
| Bvf inc/il | 2.23M | 30.13% | $7.64M |
| Blackrock funding, inc. /de | 1.23M | 16.55% | $4.91M |
| Deep track capital, lp | 1.12M | 15.14% | $3.84M |
| Stonepine capital management | 1.06M | 14.25% | $3.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Empery asset management, lp | 8.95M | 31.57% | $35.80B |
| Rosalind advisors | 2.61M | 3.66% | $10.42M |
| Stonepine capital management | 1.06M | 2.94% | $3.61M |
| Caxton | 15.56K | 1.45% | $62.23K |
| Bain capital life sciences investors | 2.44M | 0.55% | $8.33M |
| Kingdon capital management | 933.33K | 0.40% | $3.19M |
| Stempoint capital lp | 555.41K | 0.38% | $1.90M |
| Nantahala capital management | 2.45M | 0.32% | $9.80M |
| Bvf inc/il | 2.23M | 0.31% | $7.64M |
| Silverarc capital management | 357.39K | 0.20% | $1.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Empery asset management, lp | 8.95M | 31.57% | 8.95M |
| Morgan stanley | 8.21M | 0.00% | 8.20M |
| Vanguard group | 3.42M | 0.00% | 3.01M |
| Bvf inc/il | 2.23M | 0.31% | 2.23M |
| Blackrock | 10.68M | 0.00% | 1.94M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nea management company | 499.56K | 0.07% | -14.49M |
| Orbimed advisors | - | - | -6.78M |
| Adage capital partners gp | - | - | -4.28M |
| Soleus capital management | - | - | -4.05M |
| Perceptive advisors | - | - | -3.55M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Empery asset management, lp | 8.95M | 31.57% | 8.95M | $35.80B |
| Bvf inc/il | 2.23M | 0.31% | 2.23M | $7.64M |
| Deep track capital, lp | 1.12M | 0.11% | 1.12M | $3.84M |
| Stonepine capital management | 1.06M | 2.94% | 1.06M | $3.61M |
| Stempoint capital lp | 555.41K | 0.38% | 555.41K | $1.90M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -3.00 |
| Frazier financial advisors | -10.00 |
| Headlands | -16.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Eversource wealth advisors | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 39 | -4.88% | 36,993,131 | 170.97% | 499 | 1.47% | 30 | 42.86% | 4 | -55.56% |
| Sep 30, 2025 | 22 | -55.10% | 3,669,963 | 33.55% | 49 | 3.60% | 10 | -16.67% | 5 | -86.11% |
| Jun 30, 2025 | 32 | -66.67% | 1,495,756 | -98.48% | - | 1028.22% | 8 | -80.95% | 23 | -4.17% |
| Mar 31, 2025 | 96 | 1.05% | 98,519,817 | -1.31% | 1 | 0.06% | 42 | 10.53% | 24 | 9.09% |
| Dec 31, 2024 | 51 | -50.00% | 29,200,759 | -70.97% | 14 | 0.58% | 18 | -61.70% | 12 | -36.84% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Small Cap Growth | 3.39M | 3.72% | - |
| Vanguard US Total Market Shares ETF | 5.03M | 2.90% | 1.00 |
| Morgan Stanley Inception | 2.44M | 2.79% | 2.44M |
| Morgan Stanley Inst Inception I | 2.44M | 2.79% | 2.44M |
| Vanguard Total Stock Mkt Idx Inv | 2.49M | 2.73% | 136.02K |
| Fidelity Select Biotechnology | 2.08M | 2.29% | - |
| Fidelity Small Cap Growth K6 | 1.69M | 1.86% | - |
| EQ/Morgan Stanley Small Cap Growth K | 1.59M | 1.75% | 206.43K |
| Fidelity Advisor Biotechnology I | 1.34M | 1.48% | - |
| iShares Russell 2000 ETF | 84.03K | 1.17% | -14.31K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 23, 2025 | Craig Adam R | Executive Chairman | Buy | $250.00K |
| May 16, 2025 | Baldry Mark | Chief Commercial Officer | Buy | $2.56K |
| May 17, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $14.65K |
| Nov 15, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $4.60K |
| Jan 24, 2025 | Ragan Paula | President and CEO | Sell | $34.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 5 |
| 2024 Q4 | 1 | 7 |
XFOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools